<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03355534</url>
  </required_header>
  <id_info>
    <org_study_id>XJH-A-2017-10-10</org_study_id>
    <nct_id>NCT03355534</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine Improves Recovery After Cranial Aneurysm Surgery</brief_title>
  <acronym>DACA</acronym>
  <official_title>Effect of Dexmedetomidine on Maintenance and Recovery of Cranial Aneurysm Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhihong LU</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fourth Military Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dexmedetomidine induces analgesic and sedative effects and is reported to decrease agitation
      during emergence after general anesthesia in various surgeries. For patients undergoing
      cranial aneurysm surgeries, a calm anesthesia and emergence is important. In this study, the
      investigatorstend to observe the effect of dexmedetomidine on maintenance and recovery of
      patients undergoing cranial aneurysm surgeries.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 5, 2018</start_date>
  <completion_date type="Anticipated">December 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of coughing</measure>
    <time_frame>from end of infusing anesthetics to 2 minutes after extubation, averagely 30 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ricker's agitation-sedation score</measure>
    <time_frame>from end of infusing anesthetics to 2 minutes after extubation, averagely 30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>score of coughing</measure>
    <time_frame>from end of infusing anesthetics to 2 minutes after extubation, averagely 30 minutes</time_frame>
    <description>0=no coughing;1=intermittent coughing;2=continuous coughing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to response to verbal command</measure>
    <time_frame>from end of infusing anesthetics to response to verbal command,averagely 20 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to extubation</measure>
    <time_frame>from end of infusing anesthetics to extubation,averagely 28 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood pressure before and after extubation</measure>
    <time_frame>from end of infusing anesthetics to 2 minutes after extubation, averagely 30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood glucose before and after aneurysm embolism</measure>
    <time_frame>immediately before inserting coil and after finishing inserting coil,an average of 1 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood lactate before and after aneurysm embolism</measure>
    <time_frame>immediately before inserting coil and after finishing inserting coil,,an average of 1 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mini-mental state examination score</measure>
    <time_frame>24 hours after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Aneurysm Cerebral</condition>
  <arm_group>
    <arm_group_label>nasal dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dexmedetomidine is given nasally, saline is given intravenously</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intravenous dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>saline is given nasally, dexmedetomidine is given intravenously</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>saline is given nasally and intravenously</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous dexmedetomidine</intervention_name>
    <description>drug is intravenously infused to patients</description>
    <arm_group_label>intravenous dexmedetomidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nasal dexmedetomidine</intervention_name>
    <description>drug is nasally given to patients</description>
    <arm_group_label>nasal dexmedetomidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intravenous saline</intervention_name>
    <description>saline is given to patients intravenously</description>
    <arm_group_label>nasal dexmedetomidine</arm_group_label>
    <arm_group_label>normal saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nasal saline</intervention_name>
    <description>normal saline is given to patients nasally</description>
    <arm_group_label>intravenous dexmedetomidine</arm_group_label>
    <arm_group_label>normal saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing cerebral aneurysm embolism under general anesthesia

        Exclusion Criteria:

          -  patients with bradycardia or atrioventricular heart block

          -  patients with ASA(American Society of Anesthesiologists) status over 3

          -  patients with body mass index(BMI)â‰¥30kg/m2

          -  patients with difficulty in communication

          -  patients with ruptured aneurysm

          -  patients suspected or proved to be pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lize Xiong</last_name>
    <role>Study Chair</role>
    <affiliation>Fourth Military Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>hailong dong, MD.PhD</last_name>
    <phone>86-29-84775337</phone>
    <email>hldong9@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xijing Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>zhihong lu</last_name>
      <phone>86-29-84775343</phone>
      <email>deerlu23@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Peng K, Wu S, Liu H, Ji F. Dexmedetomidine as an anesthetic adjuvant for intracranial procedures: meta-analysis of randomized controlled trials. J Clin Neurosci. 2014 Nov;21(11):1951-8. doi: 10.1016/j.jocn.2014.02.023. Epub 2014 Jun 25.</citation>
    <PMID>24974190</PMID>
  </results_reference>
  <results_reference>
    <citation>Soliman RN, Hassan AR, Rashwan AM, Omar AM. Prospective, randomized controlled study to assess the role of dexmedetomidine in patients with supratentorial tumors undergoing craniotomy under general anesthesia. Middle East J Anaesthesiol. 2011 Feb;21(1):23-33.</citation>
    <PMID>21991729</PMID>
  </results_reference>
  <results_reference>
    <citation>Elbakry AE, Ibrahim E. Propofol-dexmedetomidine versus propofol-remifentanil conscious sedation for awake craniotomy during epilepsy surgery. Minerva Anestesiol. 2017 Dec;83(12):1248-1254. doi: 10.23736/S0375-9393.17.11873-0. Epub 2017 Jun 14.</citation>
    <PMID>28631453</PMID>
  </results_reference>
  <results_reference>
    <citation>Jun JH, Kim KN, Kim JY, Song SM. The effects of intranasal dexmedetomidine premedication in children: a systematic review and meta-analysis. Can J Anaesth. 2017 Sep;64(9):947-961. doi: 10.1007/s12630-017-0917-x. Epub 2017 Jun 21.</citation>
    <PMID>28639236</PMID>
  </results_reference>
  <results_reference>
    <citation>Sun Y, Li Y, Sun Y, Wang X, Ye H, Yuan X. Dexmedetomidine Effect on Emergence Agitation and Delirium in Children Undergoing Laparoscopic Hernia Repair: a Preliminary Study. J Int Med Res. 2017 Jun;45(3):973-983. doi: 10.1177/0300060517699467. Epub 2017 Mar 21.</citation>
    <PMID>28470100</PMID>
  </results_reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2017</study_first_submitted>
  <study_first_submitted_qc>November 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 28, 2017</study_first_posted>
  <last_update_submitted>March 7, 2018</last_update_submitted>
  <last_update_submitted_qc>March 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Fourth Military Medical University</investigator_affiliation>
    <investigator_full_name>Zhihong LU</investigator_full_name>
    <investigator_title>clinical professor</investigator_title>
  </responsible_party>
  <keyword>dexmedetomidine</keyword>
  <keyword>general anesthesia</keyword>
  <keyword>cerebral aneurysm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

